Benjamin Hickey's Net Worth

$641 Thousand

Estimate Recalculated Nov 11, 2024 08:52AM EST

Who is Benjamin Hickey?

Benjamin Hickey does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Mirati Therapeutics, Inc., HALOZYME THERAPEUTICS INC, Surface Oncology, Inc., Mural Oncology plc, and BRISTOL MYERS SQUIBB CO.

SEC CIK

Benjamin Hickey's CIK is 0001753055

Past Insider Trading and Trends

2022 was Benjamin Hickey's most active year for acquiring shares with 5 total transactions. Benjamin Hickey's most active month to acquire stocks was the month of December. 2024 was Benjamin Hickey's most active year for disposing of shares, totalling 8 transactions. Benjamin Hickey's most active month to dispose stocks was the month of December. 2023 saw Benjamin Hickey paying a total of $1,824,972.75 for 136,189 shares, this is the most they've acquired in one year. In 2021 Benjamin Hickey cashed out on 6,816 shares for a total of $867,502.13, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mirati Therapeutics, Inc. (MRTX) No price found

EVP, Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-117.03K
—
—
0
Jan 23
Form 4
-1.35%
-1.60K
$59.02
-$94,254.94
117.03K
Jan 16
Form 4
-1.73%
-2.09K
$58.92
-$123,142.80
118.63K
Jan 8
Form 4
+16.41%
17.02K
$58.75
$999,983.75
120.72K
Dec 29
Form 4
-2.10%
-2.22K
$56.67
-$125,807.40
103.69K
Dec 13
Form 4
+26.67%
22.3K
$37.00
$824,989.00
105.91K
Aug 9
Form 4
+77.07%
36.39K
—
—
83.62K
Jan 20
Form 4
-3.21%
-1.57K
$42.38
-$66,365.96
47.22K
Jan 17
Form 4
-4.10%
-2.09K
$45.37
-$94,732.56
48.79K
Jan 9
Form 4
+45.46%
15.9K
$40.41
-$131,265.65
50.88K
Dec 19 - Dec 21
Form 4
+40.76%
10.13K
$120.48
-$75,542.72
34.98K
Jan 14 - Jan 18
Form 4
-7.33%
-1.96K
$135.94
-$266,984.00
24.85K
Jan 7
Form 4
—
0
$145.39
-$147,129.84
26.81K
Scheduled
Mar 19
Form 4
+35.49%
7.02K
—
—
26.81K
Jan 15
Form 4
-9.50%
-2.08K
$216.33
-$449,524.53
19.79K
Jan 7
Form 4
∞
21.87K
—
—
21.87K
Jan 6
Form 3
—
0
—
—
0
No matching records found

HALOZYME THERAPEUTICS INC (HALO) Snapshot price: $59.21

SVP, Chief Commerical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
13.23K
$15.46
-$108,065.40
13.23K
Oct 1
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Oct 1
Form 3
—
0
—
—
0
No matching records found

Surface Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jan 3
Form 3
—
0
—
—
0
No matching records found

Mural Oncology plc (MURA) Snapshot price: $3.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
Dec 14
Form 3
—
0
—
—
0
No matching records found

BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.6

President, RayzeBio Org.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found